Viewing data from:

SYEDA

ANDA

DROSPIRENONE; ETHINYL ESTRADIOL | A090114 | XIROMED PHARMA ESPANA SL

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: YASMIN(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Syeda (2023)

Total Spending

$149K

Total Claims

2,777

Beneficiaries

744

Avg Cost/Unit

$0.88

Spending Trend

$224K(2019)→$223K(2020)→$148K(2021)→$138K(2022)→$149K(2023)

YoY Change:-7.1%

5yr CAGR:-11.1%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 3MG;0.03MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Mar 28, 2011

No patent or exclusivity listings for this strength.